Alerts

Shares of Seres Therapeutics (Nasdaq: MCRB), a research stage biotech company looking to treat gut related diseases by using the body’s own bacteria,  were down sharply in early trading on July 29 as the company announced disappointing results of its SER-109 clinical trial against the disease causing gut bacteria Clostridium… Read More

Argos Therapeutics (ARGS) announced yesterday evening the terms of its upcoming secondary stock offering, which has sent its share price down more than 15% this morning to partially offset the dilution that will occur after the offering has been completed. The company intends to raise $50 million compared to its… Read More

It’s not often a stock tanks after reporting both an earnings and revenue beat, but that’s exactly what happened to BTP Special Situations Portfolio holding Mobileye (NYSE: MBLY) this morning.In its second quarter earnings report released earlier this morning, Mobileye revealed that revenue shot up 58% year-over-year to $83.5 million. Earnings… Read More

Shares of Medidata Solutions (Nasdaq: MDSO), the leading cloud analytic software company for the biotech research space, rallied after beating earnings expectations by one cent and reaffirming its forward guidance.    The company reported results of Q2 EPS of $0.24, versus expectations of $0.23. Revenue for the quarter came in at… Read More

In the inaugural issue of Breakthrough Tech Profits, I recommended disk drive manufacturer Western Digital (WDC) as a play on growth in the SSD (solid state drive) market due to its recent acquisition of SanDisk. Although I felt the benefits from that transaction would be realized sooner than most… Read More

It’s time to take profits on the McKesson January 19, 2018 195 LEAPS Call option (MCK_011918C195) after a major gain.  I recommended its purchase on May 26, 2016 and the long term option gained 43.9% as of the close of trading on July 14, based on the entry price of… Read More

Juno Therapeutics (Nasdaq: JUNO), a company specializing in immunotherapy combined with chemotherapy and conventional cancer treatments,  was rallying in early trading today, just five days after a massive 30 plus percent drop in price after two unexpected deaths occurred in a critical Phase II trial for end stage leukemia patients… Read More

Juno Therapeutics (JUNO) announced this morning that it has halted its mid-stage trial study on JCAR015, a leukemia treatment that has resulted in the death of two participants in the study group. At this time there is not enough information available to determine the extent to which this development… Read More

Shares of The WhiteWave Foods Company (WWAV), a leader in organic and non-GMO food products, are trading significantly higher this morning on news that it received a $12.5 billion all-cash buyout offer from France’s Danone Foods, valuing shares of WhiteWave at $56.25, an 18% premium over its closing price on… Read More